This user has not added any information to their profile yet.
Dr. Ruth Wu-Wong is currently Vidasym’s President and CSO (www.vidasym.com ). Before joining Vidasym in 2009, Ruth was with Abbott (now AbbVie) for 20+ years where she played a key role in the development of endothelin receptor antagonists including atrasentan which is in clinical studies for diabetic nephropathy. She was the lead scientist on several novel-target projects at Abbott including the vitamin D receptor modulator project until the project’s termination in 2007. Dr. Wu-Wong obtained her Ph.D. in biochemistry from Ohio State University and her M.B.A. in finance and management from University of Illinois.